Position
Creative Planning in Adc Therapeutics Sa
Back to the book · All holders of ADCT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $17.4K$3.53 → $3.75
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 113.2K | $399.8K | — | — | — | 0.0% |
| Q1 2026 | 79K | $296.4K | $3.75 | $17.4K | −$120.8K | 0.0% |